TSE:MFC

Manulife Financial (MFC.TO)

57.04
+0.49 (0.87%)
as of Jun 25, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Experts hold a mixed view on Manulife Financial (MFC), reflecting both cautious optimism and concerns over its growth prospects. Many analysts recognize the company's strong performance in Asian markets and wealth management, noting its potential for steady income through dividends, with several projecting double-digit growth. However, there are reservations regarding the current valuation, with some analysts suggesting a wait for market pullbacks before purchasing. Despite recent underperformance relative to peers and profit-taking activities, MFC is still viewed as a reliable long-term investment, especially for dividend-seeking investors. Concerns about broader market conditions and legacy business challenges persist, but the company's fundamentals appear solid.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
BUY ON WEAKNESS

Likes insurance names broadly in the higher rate cycle. Likes this one. Likes financials to the end of this year. Wait for a breakout, or add during the upcoming correction in the next month or two. Poised to participate in the new 4-year cycle.

WEAK BUY

Lifecos could do well in the coming period. Higher rates lower their long-term costs and help ratios. He's keener on SLF, but not by a huge distance. Not a bad time to give it a look. Heavy fixed income portfolios, which now benefit from higher rates. Now diversified holdings. Higher discount rate discounts their liabilities.

Unspecified

It pays a 5.8% dividend and has a low valuation probably because investors are worried about its exposure to commercial real estate which is $14 billion of its $47 billion market cap. A high percentage of this is office towers.

BUY

Excellent company, owns shares in company.
~5% dividend yield.
Growing middle class & population in Canada will require insurance.
Rising interest rates will decrease liabilities (good for business).

TRADE

Doesn't own any lifecos right now. Asian demographics are advantageous. Canada is slow and a steady eddy. Doesn't particularly like US John Hancock business. Tantalizing dividend yield, but shares never seem to be able to break out of a range. Trade, not a long-term investment.

BUY

Book value is $30, and it's trading below that, so you have a chance to buy it below book value. Great dividend yield. Great business in Asia is undervalued and will continue to grow. Interest rates help. Fundamentals are really strong.

BUY

Up 7.7% total return over the last 12 months. Trades below book value. As Asia continues to grow, MFC is poised to do very well long term. Resistance around $28, but if it can break through that, it will do well and you get paid to wait. Great yield of 5.6%.

BUY

Asian franchise gives it good growth potential, and that area of the world is growing faster than the others. High quality. Very well managed. Good dividend yield.

BUY

Has been a top pick of his many times. Insurers report in the coming week and it will be a confusing quarter, because there are new reporting/accounting rules that will make earnings appear lower. SLF and Industrial Alliance have more weighting in Asia than MFC, so MFC might be less stable. Likes MFC. Pays a 5.4% dividend yield.

BUY

Stable, core holding. Diversifies away from concern over banks' loan losses. Issues with US legacy businesses. Likes Asian insurance operations, will drive earnings for the long term. Yield is 5.5%.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 23/23, Up 7.4%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with MFC is progressing well.  To remain disciplined, we recommend trailing up the stop (from $21) to $24 at this time. 

HOLD

Performing pretty well. Big reopening in Asia is encouraging. Reasonable valuation. Dividend growth will continue. He prefers the P&C business as more rewarding than life insurance.

RISKY
Caller frustrated by MFC performance

The chart had a decent upward move from October to early March, but has fallen since. Has now returned to its $24 December base. Is widely held by large institutions and pension funds. More than other insurers, MFC is so tied to the S&P. $24 is good to buy, but if that breaks, MFC could fall to $20.

TOP PICK

Believes shares presenting good buying opportunity with fallout from Silicon Valley  Bank.
Strong management with large asset base (over $1.3 Trillion).
Higher interest rates are beneficial for insurance companies.
Aging global population will generate demand for wealth management services.
Trading at discount to net book value.
Paying ~5.9% dividend yield that is secure.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O’Reilly

Persistent higher interest rates help profitability. The company is well positioned to offer boomers wealth management services and they have diversified geographically.  It presently trades at 8x earnings and under book value.  The dividend is good and backed by a payout ratio under 40% of cash flow.  We recommend a stop-loss at $21, looking to achieve $29 — upside potential of 18%.  Yield 5.4%

Showing 121 to 135 of 2,281 entries